{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:17:40Z","timestamp":1792174660536,"version":"4.4.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.idc.2023.02.004","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T15:05:09Z","timestamp":1682435109000},"page":"223-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Challenges in Managing Gonorrhea and New Advances in Prevention"],"prefix":"10.1016","volume":"37","author":[{"given":"Evan C.","family":"Ewers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Curtin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.idc.2023.02.004_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"issue":"8023","key":"10.1016\/j.idc.2023.02.004_bib3","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(77)92720-9","article-title":"Clinical spectrum of gonococcal infection in women","volume":"1","author":"McCormack","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2023.02.004_bib4","unstructured":"John E., Bennett R.D. and Martin J., Blaser. mandell, douglas, and bennett\u2019s principles and practice of infectious diseases, 9 ed., 2020, Elsevier\/Saunders, Philadelphia, PA."},{"issue":"1","key":"10.1016\/j.idc.2023.02.004_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00002030-199301000-00015","article-title":"Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study","volume":"7","author":"Laga","year":"1993","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.idc.2023.02.004_bib6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/427262","article-title":"Contribution of HIV-1 infection to acquisition of sexually transmitted disease: a 10-year prospective study","volume":"191","author":"McClelland","year":"2005","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2023.02.004_bib7","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.idc.2013.08.001","article-title":"Control of Neisseria gonorrhoeae in the era of evolving antimicrobial resistance","volume":"27","author":"Barbee","year":"2013","journal-title":"Infect Dis Clin North Am"},{"issue":"2","key":"10.1016\/j.idc.2023.02.004_bib9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1037\/0278-6133.19.2.134","article-title":"Impact of combination therapies on HIV risk perceptions and sexual risk among HIV-positive and HIV-negative gay and bisexual men","volume":"19","author":"Vanable","year":"2000","journal-title":"Health Psychol"},{"issue":"2","key":"10.1016\/j.idc.2023.02.004_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1089\/apc.2011.0283","article-title":"Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: a mixed methods study","volume":"26","author":"Brooks","year":"2012","journal-title":"AIDS Patient Care STDS"},{"issue":"2","key":"10.1016\/j.idc.2023.02.004_bib11","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/PHH.0000000000001143","article-title":"Trends in condomless sex among MSM who participated in CDC-funded HIV risk-reduction interventions in the United States, 2012-2017","volume":"28","author":"Zhang Kudon","year":"2022","journal-title":"J\u00a0Public Health Manag Pract"},{"key":"10.1016\/j.idc.2023.02.004_bib15","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1111\/j.1749-6632.2011.06215.x","article-title":"Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future","volume":"1230","author":"Unemo","year":"2011","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.idc.2023.02.004_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2012.176575","article-title":"Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada","volume":"309","author":"Allen","year":"2013","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.idc.2023.02.004_bib17","doi-asserted-by":"crossref","first-page":"19833","DOI":"10.2807\/ese.16.14.19833-en","article-title":"Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010","volume":"16","author":"Ison","year":"2011","journal-title":"Euro Surveill"},{"issue":"8","key":"10.1016\/j.idc.2023.02.004_bib18","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1128\/AAC.48.8.3185-3187.2004","article-title":"Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones","volume":"48","author":"Ito","year":"2004","journal-title":"Antimicrobial Agents Chemother"},{"issue":"25","key":"10.1016\/j.idc.2023.02.004_bib19","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.25.20200-en","article-title":"Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011","volume":"17","author":"Unemo","year":"2012","journal-title":"Euro Surveill"},{"issue":"6","key":"10.1016\/j.idc.2023.02.004_bib20","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/jac\/dkt034","article-title":"Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure","volume":"68","author":"Lewis","year":"2013","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.idc.2023.02.004_bib21","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/OLQ.0b013e3182631c9f","volume":"39","author":"Starnino","year":"2012","journal-title":"Sex Transm Dis"},{"issue":"11","key":"10.1016\/j.idc.2023.02.004_bib22","doi-asserted-by":"crossref","first-page":"e627","DOI":"10.1016\/S2666-5247(21)00171-3","article-title":"WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational study","volume":"2","author":"Unemo","year":"2021","journal-title":"Lancet Microbe"},{"issue":"1","key":"10.1016\/j.idc.2023.02.004_bib23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3201\/eid1701.100397","article-title":"Ceftriaxone-resistant Neisseria gonorrhoeae, Japan","volume":"17","author":"Ohnishi","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"Pt 5","key":"10.1016\/j.idc.2023.02.004_bib24","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1099\/jmm.0.007641-0","article-title":"Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods","volume":"58","author":"Tapsall","year":"2009","journal-title":"J\u00a0Med Microbiol"},{"issue":"6","key":"10.1016\/j.idc.2023.02.004_bib25","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/jac\/dkt017","article-title":"Failure of 500\u00a0mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia","volume":"68","author":"YC","year":"2013","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"30","key":"10.1016\/j.idc.2023.02.004_bib26","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.30.20862","article-title":"Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500\u00a0mg) or cefotaxime (500\u00a0mg), Sweden, 2013 and 2014","volume":"19","author":"Golparian","year":"2014","journal-title":"Euro Surveill"},{"issue":"25","key":"10.1016\/j.idc.2023.02.004_bib27","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMc1512757","article-title":"Failure of dual antimicrobial therapy in treatment of gonorrhea","volume":"374","author":"Fifer","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.idc.2023.02.004_bib28","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3201\/eid2305.170088","article-title":"Azithromycin resistance and decreased ceftriaxone susceptibility in Neisseria gonorrhoeae, Hawaii, USA","volume":"23","author":"Papp","year":"2017","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2023.02.004_bib29","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.10.1900147","article-title":"Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018","volume":"24","author":"Eyre","year":"2019","journal-title":"Euro Surveill"},{"key":"10.1016\/j.idc.2023.02.004_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-4939-9496-0_3","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae and treatment of gonorrhea","volume":"1997","author":"Unemo","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"RR-03","key":"10.1016\/j.idc.2023.02.004_bib31","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"10.1016\/j.idc.2023.02.004_bib32","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future","volume":"27","author":"Unemo","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"10.1016\/j.idc.2023.02.004_bib33","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the infectious diseases society of America and the society for healthcare epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2023.02.004_bib36","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/sextrans-2018-053803","article-title":"Evidence for a new paradigm of gonorrhoea transmission: cross-sectional analysis of Neisseria gonorrhoeae infections by anatomical site in both partners in 60 male couples","volume":"95","author":"Cornelisse","year":"2019","journal-title":"Sex Transm Infect"},{"issue":"10190","key":"10.1016\/j.idc.2023.02.004_bib37","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/S0140-6736(18)32817-4","article-title":"Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial","volume":"393","author":"Ross","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2023.02.004_bib38","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12879-015-1029-2","article-title":"Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge","volume":"15","author":"Unemo","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2023.02.004_bib39","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1016\/S1473-3099(20)30171-7","article-title":"Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodynamics, therapeutic strategies, and molecular resistance prediction","volume":"20","author":"Sena","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2023.02.004_bib40","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.cmi.2020.08.006","article-title":"Pharmacokinetic\/pharmacodynamic considerations for new and current therapeutic drugs for uncomplicated gonorrhoea-challenges and opportunities","volume":"26","author":"Theuretzbacher","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"10.1016\/j.idc.2023.02.004_bib41","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S1473-3099(19)30116-1","article-title":"Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): a randomised phase 3 non-inferiority trial","volume":"19","author":"Chen","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2023.02.004_bib42","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02047-16","article-title":"In\u00a0Vitro Activity of Gepotidacin (GSK2140944) against Neisseria gonorrhoeae","volume":"61","author":"Farrell","year":"2017","journal-title":"Antimicrobial Agents Chemother"},{"issue":"9","key":"10.1016\/j.idc.2023.02.004_bib43","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1128\/AAC.03090-14","article-title":"High in\u00a0vitro activity of the novel spiropyrimidinetrione AZD0914, a DNA gyrase inhibitor, against multidrug-resistant Neisseria gonorrhoeae isolates suggests a new effective option for oral treatment of gonorrhea","volume":"58","author":"Jacobsson","year":"2014","journal-title":"Antimicrobial Agents Chemother"},{"issue":"19","key":"10.1016\/j.idc.2023.02.004_bib44","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1056\/NEJMoa1706988","article-title":"Single-dose zoliflodacin (ETX0914) for treatment of urogenital gonorrhea","volume":"379","author":"Taylor","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.idc.2023.02.004_bib45","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/cid\/ciy145","article-title":"Gepotidacin for the treatment of uncomplicated urogenital gonorrhea: a phase 2, randomized, dose-ranging, single-oral dose evaluation","volume":"67","author":"Taylor","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2023.02.004_bib46","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S1473-3099(21)00625-3","article-title":"Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trial","volume":"22","author":"de Vries","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2023.02.004_bib47","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01497-17","article-title":"In\u00a0vitro activity of the novel pleuromutilin lefamulin (BC-3781) and effect of efflux pump inactivation on multidrug-resistant and extensively drug-resistant Neisseria gonorrhoeae","volume":"61","author":"Jacobsson","year":"2017","journal-title":"Antimicrobial Agents Chemother"},{"issue":"RR-02","key":"10.1016\/j.idc.2023.02.004_bib48","first-page":"1","article-title":"Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014","volume":"63","year":"2014","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"issue":"3","key":"10.1016\/j.idc.2023.02.004_bib49","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/sti.2008.034140","article-title":"Detection of Neisseria gonorrhoeae and chlamydia trachomatis in pharyngeal and rectal specimens using the BD probetec ET system, the gen-probe aptima combo 2 assay and culture","volume":"85","author":"Ota","year":"2009","journal-title":"Sex Transm Infect"},{"issue":"4","key":"10.1016\/j.idc.2023.02.004_bib50","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.diagmicrobio.2015.08.005","article-title":"Comparison between conventional culture and NAATs for the microbiological diagnosis in gonococcal infection","volume":"83","author":"Serra-Pladevall","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2023.02.004_bib51","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1128\/JCM.03223-12","article-title":"Comparison of the cobas 4800 CT\/NG test with culture for detecting Neisseria gonorrhoeae in genital and nongenital specimens in a low-prevalence population in New Zealand","volume":"51","author":"Bromhead","year":"2013","journal-title":"J\u00a0Clin Microbiol"},{"issue":"5","key":"10.1016\/j.idc.2023.02.004_bib52","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1128\/JCM.02398-09","article-title":"Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and chlamydia trachomatis rectal infections","volume":"48","author":"Bachmann","year":"2010","journal-title":"J\u00a0Clin Microbiol"},{"issue":"4","key":"10.1016\/j.idc.2023.02.004_bib53","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1586\/14737159.6.4.519","article-title":"APTIMA transcription-mediated amplification assays for chlamydia trachomatis and Neisseria gonorrhoeae","volume":"6","author":"Chernesky","year":"2006","journal-title":"Expert Rev Mol Diagn"},{"issue":"2","key":"10.1016\/j.idc.2023.02.004_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9020091","article-title":"The laboratory diagnosis of Neisseria gonorrhoeae: current testing and future demands","volume":"9","author":"Meyer","year":"2020","journal-title":"Pathogens"},{"issue":"12","key":"10.1016\/j.idc.2023.02.004_bib55","doi-asserted-by":"crossref","first-page":"e0189515","DOI":"10.1371\/journal.pone.0189515","article-title":"Comparing mail-in self-collected specimens sent via United States Postal Service versus clinic-collected specimens for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in extra-genital sites","volume":"12","author":"Salow","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.idc.2023.02.004_bib56","series-title":"Mapping the landscape of diagnostics for sexually transmitted infections : key findings and recommendations\/Hannah Kettler, Karen White, Sarah Hawkes","author":"Kettler","year":"2004"},{"key":"10.1016\/j.idc.2023.02.004_bib57","article-title":"Impact of point-of-care testing on the management of sexually transmitted infections in South Africa: Evidence from the HVTN702 HIV vaccine trial","author":"Asare","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"8S","key":"10.1016\/j.idc.2023.02.004_bib58","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1097\/OLQ.0000000000001457","article-title":"A\u00a0narrative review of where we are with point-of-care sexually transmitted infection testing in the United States","volume":"48","author":"Gaydos","year":"2021","journal-title":"Sex Transm Dis"},{"issue":"11S Suppl 2","key":"10.1016\/j.idc.2023.02.004_bib59","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1097\/OLQ.0000000000001597","article-title":"Advances in sexually transmitted infection testing at home and in nonclinical settings close to the home","volume":"49","author":"Kersh","year":"2022","journal-title":"Sex Transm Dis"},{"issue":"9","key":"10.1016\/j.idc.2023.02.004_bib60","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1093\/cid\/ciz1105","article-title":"Simultaneous evaluation of diagnostic assays for pharyngeal and rectal Neisseria gonorrhoeae and chlamydia trachomatis using a master protocol","volume":"71","author":"Doernberg","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2023.02.004_bib61","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S1473-3099(20)30734-9","article-title":"Performance of a single-use, rapid, point-of-care PCR device for the detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis: a cross-sectional study","volume":"21","author":"Morris","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2023.02.004_bib62","doi-asserted-by":"crossref","first-page":"e204819","DOI":"10.1001\/jamanetworkopen.2020.4819","article-title":"Evaluation of the performance of a point-of-care test for chlamydia and gonorrhea","volume":"3","author":"Van Der Pol","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.idc.2023.02.004_bib63","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/14737159.2017.1360137","article-title":"Recent advances in the development and use of molecular tests to predict antimicrobial resistance in Neisseria gonorrhoeae","volume":"17","author":"Dona","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"issue":"1","key":"10.1016\/j.idc.2023.02.004_bib64","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13073-021-00860-8","article-title":"Emergence and evolution of antimicrobial resistance genes and mutations in Neisseria gonorrhoeae","volume":"13","author":"Yahara","year":"2021","journal-title":"Genome Med"},{"issue":"4","key":"10.1016\/j.idc.2023.02.004_bib65","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/jac\/dkz530","article-title":"Emergence of ceftriaxone-resistant Neisseria gonorrhoeae strains harbouring a novel mosaic penA gene in China","volume":"75","author":"Xiu","year":"2020","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.idc.2023.02.004_bib66","doi-asserted-by":"crossref","first-page":"820998","DOI":"10.3389\/fmicb.2021.820998","article-title":"First national genomic epidemiological study of Neisseria gonorrhoeae strains spreading across Sweden in 2016","volume":"12","author":"Hadad","year":"2021","journal-title":"Front Microbiol"},{"issue":"7","key":"10.1016\/j.idc.2023.02.004_bib67","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1128\/AAC.00504-16","article-title":"New ceftriaxone- and multidrug-resistant Neisseria gonorrhoeae strain with a novel Mosaic penA gene isolated in Japan","volume":"60","author":"Nakayama","year":"2016","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.idc.2023.02.004_bib68","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciac371","article-title":"Resistance-guided therapy for Neisseria gonorrhoeae","author":"Allan-Blitz","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2023.02.004_bib69","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/cid\/ciaa596","article-title":"Resistance-guided treatment of gonorrhea: a prospective clinical study","volume":"73","author":"Klausner","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2023.02.004_bib70","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/0956462419886775","article-title":"2018\u00a0UK national guideline for the management of infection with Neisseria gonorrhoeae","volume":"31","author":"Fifer","year":"2020","journal-title":"Int J STD AIDS"},{"issue":"1","key":"10.1016\/j.idc.2023.02.004_bib71","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/jac\/dkaa381","article-title":"Evaluation of the SpeeDx ResistancePlus(R) GC and SpeeDx GC 23S 2611 (beta) molecular assays for prediction of antimicrobial resistance\/susceptibility to ciprofloxacin and azithromycin in Neisseria gonorrhoeae","volume":"76","author":"Hadad","year":"2021","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.idc.2023.02.004_bib72","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/OLQ.0000000000001170","volume":"47","author":"Abara","year":"2020","journal-title":"Sex Transm Dis"},{"issue":"6","key":"10.1016\/j.idc.2023.02.004_bib73","doi-asserted-by":"crossref","first-page":"e0250557","DOI":"10.1371\/journal.pone.0250557","article-title":"Trends in asymptomatic STI among HIV-positive MSM and lessons for systematic screening","volume":"16","author":"Farfour","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.idc.2023.02.004_bib74","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1086\/430704","article-title":"Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003","volume":"41","author":"Kent","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2023.02.004_bib75","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/OLQ.0b013e31822a2b2e","article-title":"Infections missed by urethral-only screening for chlamydia or gonorrhea detection among men who have sex with men","volume":"38","author":"Marcus","year":"2011","journal-title":"Sex Transm Dis"},{"issue":"10","key":"10.1016\/j.idc.2023.02.004_bib76","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jama.2021.14081","article-title":"Screening for chlamydia and gonorrhea: US preventive services task force recommendation statement","volume":"326","author":"Davidson","year":"2021","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.idc.2023.02.004_bib77","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/cid\/ciu184","article-title":"Extragenital gonorrhea and chlamydia testing and infection among men who have sex with men--STD Surveillance Network, United States, 2010-2012","volume":"58","author":"Patton","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2023.02.004_bib78","doi-asserted-by":"crossref","DOI":"10.1136\/sextrans-2021-055361","article-title":"High proportions of rectal and pharyngeal chlamydia and gonorrhoea cases among cisgender men are missed using current CDC screening recommendations","author":"Assaf","year":"2022","journal-title":"Sex Transm Infect"},{"issue":"10","key":"10.1016\/j.idc.2023.02.004_bib79","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/OLQ.0000000000000320","article-title":"Barriers to bacterial sexually transmitted infection testing of HIV-infected men who have sex with men engaged in HIV primary care","volume":"42","author":"Barbee","year":"2015","journal-title":"Sex Transm Dis"},{"issue":"S2","key":"10.1016\/j.idc.2023.02.004_bib80","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1089\/apc.2022.0078","article-title":"Automated sexual history and self-collection of extragenital chlamydia and gonorrhea improve detection of bacterial sexually transmitted infections in people with HIV","volume":"36","author":"Chapman","year":"2022","journal-title":"AIDS Patient Care STDS"},{"issue":"7","key":"10.1016\/j.idc.2023.02.004_bib81","doi-asserted-by":"crossref","first-page":"e0132776","DOI":"10.1371\/journal.pone.0132776","article-title":"Self-Collected versus clinician-collected sampling for chlamydia and gonorrhea screening: a systemic review and meta-analysis","volume":"10","author":"Lunny","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.idc.2023.02.004_bib82","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1128\/JCM.02269-08","article-title":"Evaluation of self-collected glans and rectal swabs from men who have sex with men for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of nucleic acid amplification tests","volume":"47","author":"Moncada","year":"2009","journal-title":"J\u00a0Clin Microbiol"},{"issue":"9","key":"10.1016\/j.idc.2023.02.004_bib83","doi-asserted-by":"crossref","first-page":"e3172","DOI":"10.1093\/cid\/ciaa1266","volume":"73","author":"Wilson","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2023.02.004_bib84","article-title":"Perceptions and experiences of returning self-collected specimens for HIV, bacterial STI and potential PrEP adherence testing among sexual minority men in the United States","author":"Sharma","year":"2022","journal-title":"AIDS Behav"},{"issue":"1","key":"10.1016\/j.idc.2023.02.004_bib85","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12916-021-02160-9","article-title":"Diagnostic accuracy of pooling urine, anorectal, and oropharyngeal specimens for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae: a systematic review and meta-analysis","volume":"19","author":"Aboud","year":"2021","journal-title":"BMC Med"},{"issue":"7","key":"10.1016\/j.idc.2023.02.004_bib86","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa041681","article-title":"Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection","volume":"352","author":"Golden","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.idc.2023.02.004_bib87","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1086\/432476","article-title":"Patient-delivered partner treatment for male urethritis: a randomized, controlled trial","volume":"41","author":"Kissinger","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2023.02.004_bib88","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/OLQ.0b013e31822e9192","article-title":"The cost and cost-effectiveness of expedited partner therapy compared with standard partner referral for the treatment of chlamydia or gonorrhea","volume":"38","author":"Gift","year":"2011","journal-title":"Sex Transm Dis"},{"issue":"9","key":"10.1016\/j.idc.2023.02.004_bib89","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/OLQ.0000000000000329","article-title":"Patient-reported expedited partner therapy for gonorrhea in the United States: findings of the STD surveillance network 2010-2012","volume":"42","author":"Stenger","year":"2015","journal-title":"Sex Transm Dis"},{"issue":"1","key":"10.1016\/j.idc.2023.02.004_bib90","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/OLQ.0000000000001479","article-title":"Gonorrhea and chlamydia cases are rising in the United States: expedited partner therapy might help","volume":"49","author":"Nelson","year":"2022","journal-title":"Sex Transm Dis"},{"issue":"1","key":"10.1016\/j.idc.2023.02.004_bib91","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12916-017-0858-9","article-title":"Expedited partner therapy (EPT) increases the frequency of partner notification among MSM in Lima, Peru: a pilot randomized controlled trial","volume":"15","author":"Clark","year":"2017","journal-title":"BMC Med"},{"issue":"11","key":"10.1016\/j.idc.2023.02.004_bib92","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/OLQ.0000000000001058","article-title":"Epidemiological impact of expedited partner therapy for men who have sex with men: a modeling study","volume":"46","author":"Weiss","year":"2019","journal-title":"Sex Transm Dis"},{"issue":"36","key":"10.1016\/j.idc.2023.02.004_bib93","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1016\/j.vaccine.2015.07.015","article-title":"The potential impact of vaccination on the prevalence of gonorrhea","volume":"33","author":"Craig","year":"2015","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.idc.2023.02.004_bib94","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/infdis\/jiab581","article-title":"A\u00a0gonococcal vaccine has the potential to rapidly reduce the incidence of Neisseria gonorrhoeae infection among urban men who have sex with men","volume":"225","author":"Hui","year":"2022","journal-title":"J\u00a0Infect Dis"},{"issue":"10102","key":"10.1016\/j.idc.2023.02.004_bib95","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(17)31449-6","article-title":"Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study","volume":"390","author":"Petousis-Harris","year":"2017","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.idc.2023.02.004_bib96","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S1473-3099(21)00812-4","article-title":"Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: a retrospective observational study","volume":"22","author":"Abara","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2023.02.004_bib97","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S1473-3099(21)00754-4","article-title":"Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: an observational cohort and case-control study","volume":"22","author":"Wang","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2023.02.004_bib98","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/OLQ.0000000000000216","article-title":"Doxycycline prophylaxis to reduce incident syphilis among HIV-infected men who have sex with men who continue to engage in high-risk sex: a randomized, controlled pilot study","volume":"42","author":"Bolan","year":"2015","journal-title":"Sex Transm Dis"},{"issue":"3","key":"10.1016\/j.idc.2023.02.004_bib99","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1473-3099(17)30725-9","article-title":"Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial","volume":"18","author":"Molina","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idc.2023.02.004_bib100","unstructured":"Leutkemeyer A, Dombrowski J, Cohen S, et al. Doxycycline post-exposure prophylaxis for STI prevention among MSM and transgender women on HIV PrEP or living with HIV: high efficacy to reduce incident STI's in a randomized trial. 2022. https:\/\/programme.aids2022.org\/Abstract\/Abstract\/?abstractid=13231. at AIDS 2022 in Montreal, Canada, July 29 to August 2, 2022."}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552023000144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552023000144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:31:46Z","timestamp":1760196706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552023000144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":93,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0891552023000144"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2023.02.004","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges in Managing Gonorrhea and New Advances in Prevention","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2023.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}